Finding a clinical trial for a cancer patient demands extraordinary effort as it requires evaluating many available trial opportunities against specific patient characteristics. Ancora.ai accelerates clinical trial recruitment by systematically and seamlessly connecting patients to trials. Our proprietary technology structures jargon-laden clinical trial protocols into an easy to use interface to match any patient to trials at scale. Our best-in-class trial matching solution means we can more efficiently and effectively match highly qualified patients to the right trials, thereby transforming the $44B. clinical research industry to be data-driven & enabling precision medicine recruitment.
Location: Switzerland, Zurich
Investors 1
Date | Name | Website |
30.01.2024 | VentureLab | venturelab... |
Mentions in press and media 6
Date | Title | Description | Source |
14.12.2023 | Ten startups join the 2024 roadshow in Barcelona | startuptic... | |
26.09.2023 | Future of Health Grant kicks off with new cohort | startuptic... | |
12.09.2023 | Four Swiss startups enter the DayOne Health 4.0 Accelerator | startuptic... | |
16.12.2021 | Ancora completes pre-seed round | startuptic... | |
18.11.2021 | Las 65 empresas partner de BIND 4.0 eligen 79 startups como ... | 18/11/2021 Nota de prensa LAS 65 EMPRESAS PARTNER DE BIND 4.0 ELIGEN 79 STARTUPS COMO FINALISTAS D... | webcapital... |
21.10.2020 | Healthtech and greentech dominate the DT50 startup awards | The winners of the 2020 DT50 awards have been chosen, and the field was led by healthtech and greent... | sifted.eu/... |